SenderraRx Achieves Reaccreditation with Oncology Distinction from ACHC

SenderraRx Achieves New Heights in Specialty Pharmacy

In a significant milestone, SenderraRx has successfully earned reaccreditation in Specialty Pharmacy from the Accreditation Commission for Health Care (ACHC), along with a distinguished recognition in Oncology. This reaccreditation serves as a testament to the organization’s dedication to achieving excellence in quality care, safety, and patient service.

What Does Reaccreditation Mean?

Reaccreditation is a rigorous process that entails an independent evaluation of an organization against nationally recognized standards. For SenderraRx, this means not only maintaining high-quality pharmacy services but also enhancing the patient experience through thorough clinical oversight, medication management, and patient education. The integration of these practices affirms the commitment to providing comprehensive care, particularly for patients navigating the complexities of cancer therapies.

Will Howard, CEO of Senderra Specialty Pharmacy, commented on this achievement, stating, "This recognition reflects the expertise and commitment our team brings to patients navigating complex cancer therapies. Our role extends beyond dispensing medication. We help patients understand their treatment, coordinate with their care teams, and overcome challenges that could interrupt therapy." This patient-centered approach is integral to SenderraRx's operations, ensuring that all patients receive the highest quality care tailored to their specific needs.

Distinction in Oncology

The Oncology Distinction awarded to SenderraRx highlights its specialized capabilities in supporting patients with cancer. This recognition points to the pharmacy’s unique role in managing complex treatment regimens, allowing for seamless communication between healthcare providers and patients. The oncology-focused oversight not only advances patient safety but also enhances treatment adherence, ultimately leading to better health outcomes for those affected by cancer.

Furthermore, the strategies employed by SenderraRx include medication management and adherence support, which are critical in the health sector, especially for patients facing difficult treatment paths. The organization equips patients with the necessary tools and knowledge, facilitating a smoother journey throughout their treatment.

Maintaining High Standards through Accreditation

The reaccreditation from ACHC complements SenderraRx's existing certifications from URAC in Specialty Pharmacy and Mail Service Pharmacy. Holding both ACHC and URAC accreditations underscores SenderraRx's steadfast approach in delivering high-quality services and meeting stringent industry standards.

To add to their accolades, accreditation from recognized bodies like ACHC and URAC is often viewed as a vital indicator of a pharmacy's competence in specialty services. These recognitions are not just badges of honor; they significantly enhance SenderraRx's collaborative efforts with health plans, pharmacy benefit managers, and pharmaceutical manufacturers, fortifying their position within the specialty pharmacy network and limited-distribution program arenas.

The Importance of Quality Indicators

Quality markers such as accreditation are increasingly important in the healthcare marketplace. They provide assurance to patients and other stakeholders regarding the pharmacy’s commitment to excellence. In addition, maintaining a recognized standard supports SenderraRx in forging partnerships with payers and pharmaceutical manufacturers, facilitating a better overall network of care.

More About SenderraRx

SenderraRx is the leading independent specialty pharmacy in the nation, focused on providing not just medications, but a host of clinical management and patient services for individuals with complex and chronic conditions. The incorporation of cutting-edge technology enhances both the patient and provider journey, thereby promoting greater accessibility to necessary healthcare services.

The organization synergizes efforts with patients, prescribers, pharmaceutical manufacturers, and payer partners to ensure a seamless therapy coordination, access assurance, and continuity of care for everyone it serves. For further information on SenderraRx, visit www.senderrarx.com.

About ACHC

The Accreditation Commission for Health Care (ACHC) is a nonprofit organization established in 1986, recognized for offering comprehensive accreditation programs to pharmacies and various healthcare providers. Through its Specialty Pharmacy Accreditation, ACHC evaluates policies, processes, and patient outcomes against industry benchmarks, and honors organizations with distinctions that showcase advanced expertise in specialized areas like oncology.

Conclusion

The recent reaccreditation and Oncology Distinction awarded to SenderraRx significantly affirm its unwavering commitment to patient-centered care and operational excellence. By focusing on quality and patient outcomes, SenderraRx continues to set the standard in specialty pharmacy services.